These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32998070)

  • 1. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
    Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
    Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of colorectal carcinoma screening amongst patients attending a public primary care health centre in Johor Bahru.
    Rizky NPH; Aznida FAA; Wan Fadhilah WI
    Med J Malaysia; 2021 May; 76(3):346-352. PubMed ID: 34031333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
    Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
    BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
    Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
    J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of colorectal cancer screening programme in Malaysia.
    Arunah C; Feisul IM; Nor Saleha IT; Muhammad Radzi AH
    Med J Malaysia; 2020 May; 75(3):235-239. PubMed ID: 32467538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
    Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
    PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia.
    Abu Hassan MR; Leong TW; Othman Andu DF; Hat H; Nik Mustapha NR
    Asian Pac J Cancer Prev; 2016; 17(2):569-73. PubMed ID: 26925645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
    Yang H; Ge Z; Dai J; Li X; Gao Y
    Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Intention and Uptake of Colorectal Cancer Screening after a Brief Health Education Program in a Malaysian Primary Care Setting: A Population-Based Study.
    Chan MW; Chean KY; Kader Maideen SF; Kow FP
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3475-3482. PubMed ID: 34837902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Colorectal Cancer Screening Via Immunochemical Fecal Occult Blood Test in an Average-Risk Population From a Multiethnic, Middle-Income Setting.
    Bujang NN; Lee YJ; Mohd-Zain SA; Aris JH; Md-Yusoff FA; Suli Z; Abu-Hassan MR; Bhoo-Pathy N
    JCO Glob Oncol; 2021 Feb; 7():333-341. PubMed ID: 33625866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
    Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
    PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
    Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioneering Annual Colorectal Cancer Screening and Treatment Targeting Low Income Communities in Malaysia (20102015).
    Tze CN; Fitzgerald H; Qureshi A; Tan HJ; Low ML
    Asian Pac J Cancer Prev; 2016; 17(7):3179-83. PubMed ID: 27509948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
    Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
    BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
    Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening among government servants in Brunei Darussalam.
    Chong VH; Bakar S; Sia R; Lee J; Kassim N; Rajak L; Abdullah MS; Chong CF
    Asian Pac J Cancer Prev; 2013; 14(12):7657-61. PubMed ID: 24460349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.